Burosumab-twza Subcutaneous and Lithium Capsules and Tablets
Determining the interaction of Burosumab-twza Subcutaneous and Lithium Capsules and Tablets and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: burosumab
Brand name: Crysvita
Synonyms: Burosumab
Generic Name: lithium
Brand name: Lithobid, Eskalith, Lithonate, Lithotabs, Eskalith-CR
Synonyms: Lithium
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Burosumab-twza Subcutaneous-Lithium Carbonate
- Burosumab-twza Subcutaneous-Lithium Carbonate ER Tablets
- Burosumab-twza Subcutaneous-Lithium Carbonate Tablets
- Burosumab-twza Subcutaneous-Lithium Citrate Syrup
- Burosumab-twza Subcutaneous-Lithium Controlled-Release and Extended-Release Tablets
- Burosumab-twza Subcutaneous-Lithium ER
- Lithium Capsules and Tablets-Buspar
- Lithium Capsules and Tablets-Buspar Dividose
- Lithium Capsules and Tablets-Buspirone
- Lithium Capsules and Tablets-Buspirone Hydrochloride
- Lithium Capsules and Tablets-Busulfan
- Lithium Capsules and Tablets-Busulfan Concentrate Injection